Utah Medical Products extends tender offer for Utah Medical Products stock

Published on 10/15/2026 at 12:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The offer covers 650,000 shares at USD 75.00 through October 27, 2026. Utah Medical Products stock costs EUR 67.50 on October 15, 2026.

Tender offer timeline

Utah Medical Products extended its tender offer on October 5, 2026, covering 650,000 shares.
First-half 2026 revenue fell 12.30 percent to USD 17.3 million.
Utah Medical Products stock trades at EUR 67.50 at 12:31 p.m. CEST at Lang & Schwarz on October 15, 2026.
Third-quarter 2026 results are scheduled for October 22, 2026.

UTMD, US9174881089, Illustration mit AI erstellt.

Utah Medical Products (ISIN US9174881089) was trading at EUR 67.50 at Lang & Schwarz on October 15, 2026 at 12:31 p.m. CEST. According to Guard Online, the company extended its self-tender offer on October 5, 2026, to purchase up to 650,000 shares at USD 75.00 per share, with the deadline moved to October 27, 2026.

Tender offer timeline

On September 15, 2026, Utah Medical Products announced a self-tender for 20.00 percent of its shares, according to StockTitan. The company commenced the offer on September 24, 2026, for up to 650,000 shares at USD 75.00, and extended the expiration date on October 5, 2026, from October 7 to October 27.

What does the offer mean for margins?

The buyback decision arrives after a weaker first half. Yahoo Finance reported that first-half 2026 revenue fell 12.30 percent to USD 17.3 million, while operating income declined 17.90 percent to USD 5.2 million. Even so, the company posted a 58.20 percent gross margin and a 30.20 percent operating margin for the period.

Next dates for shareholders

Utah Medical Products is scheduled to announce calendar third-quarter 2026 results on October 22, 2026, before the tender offer expires at 5:00 p.m. New York time on October 27, 2026. The timing gives shareholders a reported results milestone before the offer deadline, while the fixed USD 75.00 price remains the central corporate-action figure.

Stock price in Germany

The company trades on the NASDAQ under the ticker UTMD and develops specialty medical devices for women's health, childbirth and neonatal care. Its investor-relations page says the common stock trades on the NASDAQ Global Market, while the finance profile classifies the company in Healthcare and Medical Instruments and Supplies.

Utah Medical Products stock was trading at EUR 67.50 at Lang & Schwarz on October 15, 2026 at 12:31 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of UTMD stock.